Letter of intent to fund Vacs, page-74

Great post 1mission,

I would just like to say that personally I see much more upside from Adapt / 3D / TAVR than I do from the vaccine tech. Of course this is only speculation as who really knows.

I just see a much higher chance of success, with much less investment and a far easier partnership pathway. So while it may be disappointing to some that we have reduced our stake (30% is still great exposure) we really do have tremendous upside and blue sky in our little company with Adapt.

What a year this will turn our to be.

DYOR and Not advice